Literature DB >> 18820865

Pathological predictors for lymph node metastasis in T1 colorectal cancer.

Hitoshi Yamauchi1, Kazutomo Togashi, Yutaka J Kawamura, Hisanaga Horie, Junichi Sasaki, Shingo Tsujinaka, Yoshikazu Yasuda, Fumio Konishi.   

Abstract

PURPOSE: To clarify pathological predictor for lymph node metastasis in T1 colorectal cancer.
METHODS: One hundred and sixty-four patients who underwent surgery for single T1 colorectal cancer were reviewed. The pathological differentiations of non-well differentiation, invasion depth (> or =2 000 microm), lymphatic channel involvement, venous invasion, and tumor budding were selected as candidate predictors. Tumor budding was estimated according to the definition proposed by Ueno et al. (Gastroenterology 2004; 127:385-394). The lymph node status was set for the endpoint. Logistic regression model was applied to analyze the predictors.
RESULTS: Lymph node involvement was observed in 9.8%. The positive rates were 13.4% for the pathological differentiations of non-well differentiation, 51.8% for invasion depth (> or =2 000 microm), 6.1% for lymphatic channel involvement, 8.5% for venous invasion, and 14.6% for tumor budding. The pathological differentiations of non-well differentiation (P < 0.001) and tumor budding (P = 0.002) were significantly associated with lymph node metastasis in multivariate analysis. When either two significant factors was adopted for the prediction of the lymph node metastasis, the sensitivity, specificity, positive predictive value, and negative predictive value were 94%, 82%, 36%, and 99%, respectively.
CONCLUSION: The pathological differentiations of non-well differentiation and tumor budding are useful predictors for lymph node metastasis in T1 colorectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18820865     DOI: 10.1007/s00595-007-3751-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.

Authors:  Huann-Sheng Wang; Wen-Yih Liang; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Shung-Haur Yang; Shih-Ching Chang; Jen-Kou Lin
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

2.  Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis.

Authors:  S Tanaka; K Haruma; C R Teixeira; S Tatsuta; N Ohtsu; Y Hiraga; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

3.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

4.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

6.  Risk factor assessment of endoscopically removed malignant colorectal polyps.

Authors:  P Netzer; C Forster; R Biral; C Ruchti; J Neuweiler; E Stauffer; R Schönegg; C Maurer; J Hüsler; F Halter; A Schmassmann
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

7.  New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion.

Authors:  Tetsuya Shimomura; Shingo Ishiguro; Hideyuki Konishi; Naoki Wakabayashi; Shoji Mitsufuji; Tsutomu Kasugai; Masayuki Manou; Tadashi Kodama
Journal:  J Gastroenterol Hepatol       Date:  2004-01       Impact factor: 4.029

8.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

9.  The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy?

Authors:  S Kyzer; L R Bégin; P H Gordon; B Mitmaker
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

10.  Endoscopically removed malignant colorectal polyps: clinicopathologic correlations.

Authors:  H S Cooper; L M Deppisch; W K Gourley; E I Kahn; R Lev; P N Manley; R R Pascal; A H Qizilbash; R R Rickert; J F Silverman
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

View more
  22 in total

1.  Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer.

Authors:  Shuji Iida; Hirotoshi Hasegawa; Koji Okabayashi; Konosuke Moritani; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

Review 3.  Tumour budding in colorectal cancer: what do we know and what can we do?

Authors:  Linde De Smedt; Sofie Palmans; Xavier Sagaert
Journal:  Virchows Arch       Date:  2015-11-27       Impact factor: 4.064

Review 4.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.

Authors:  F Petrelli; E Pezzica; M Cabiddu; A Coinu; K Borgonovo; M Ghilardi; V Lonati; D Corti; S Barni
Journal:  J Gastrointest Cancer       Date:  2015-09

5.  Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC.

Authors:  Konrad Steinestel; Jochen K Lennerz; Stefan Eder; Klaus Kraft; Annette Arndt
Journal:  Virchows Arch       Date:  2014-06-12       Impact factor: 4.064

6.  Factors influencing apical node metastasis in colorectal cancer patients treated with laparoscopic radical resection with D3 lymphadenectomy: results from two centers in China.

Authors:  Hongyuan Chen; Yanan Wang; Hao Liu; Yanfeng Hu; Liying Zhao; Guoxin Li; Pan Chi
Journal:  Surg Today       Date:  2014-08-22       Impact factor: 2.549

7.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  The concurrence of histologically positive resection margins and sessile morphology is an important risk factor for lymph node metastasis after complete endoscopic removal of malignant colorectal polyps.

Authors:  Lars Boenicke; Martin Fein; Marco Sailer; Christoph Isbert; Christoph-Tomas Germer; Andreas Thalheimer
Journal:  Int J Colorectal Dis       Date:  2009-11-06       Impact factor: 2.571

Review 9.  Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis.

Authors:  Shanshan Mou; Roy Soetikno; Tadakasu Shimoda; Robert Rouse; Tonya Kaltenbach
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

10.  Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.

Authors:  Hideki Ueno; Kazuo Hase; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinji Yoshii; Shin-ei Kudo; Masafumi Tanaka; Yoshito Akagi; Takeshi Suto; Shinji Nagata; Keiji Matsuda; Koji Komori; Kazuhiko Yoshimatsu; Yasuhiko Tomita; Shozo Yokoyama; Eiji Shinto; Takahiro Nakamura; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2013-09-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.